
Similar efficacy and safety between PG201 and SKI306X herbal medicines for knee OA

Similar efficacy and safety between PG201 and SKI306X herbal medicines for knee OA
Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis
J Ethnopharmacol. 2016 Apr 2;181:1-7Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
124 patients with mild-to-moderate symptomatic knee osteoarthritis were randomized to daily treatment with tablets of either PG201, a 12-herb formulation, or SKI306X, a 3-herb formulation. The purpose of this study was to evaluate if PG201 demonstrated non-inferior efficacy and safety compared to SKI306X when assessed after 8 and 12 weeks. Efficacy parameters included a visual analog scale for pai...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.